Jul 6, 2023Lenalidomide Demonstrates Promising Activity in Pediatric Gliomas/AstrocytomasThe immunomodulatory agent lenalidomide (Revlimid) appeared clinically active and tolerable in pilocytic astrocytomas and optic pathway...